VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
-14.02%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$270M
AUM Growth
+$270M
(+21%)
Cap. Flow
+$74.6M
Cap. Flow
% of AUM
27.64%
Top 10 Holdings %
Top 10 Hldgs %
7.48%
Holding
501
New
128
Increased
203
Reduced
101
Closed
67
Top Buys
| 1 |
Realty Income
O
|
$925K |
| 2 |
Eli Lilly
LLY
|
$843K |
| 3 |
Moderna
MRNA
|
$824K |
| 4 |
Pfizer
PFE
|
$803K |
| 5 |
Merck
MRK
|
$796K |
Top Sells
Sector Composition
| 1 | Real Estate | 18.55% |
| 2 | Healthcare | 17.07% |
| 3 | Materials | 11.98% |
| 4 | Financials | 11.43% |
| 5 | Energy | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Kilroy Realty
KRC
$4.93B
| $1.25M | 0.46% |
23,795
-273
| -1% | -$14.3K |
|
77
Gerdau
GGB
$6.05B
| $1.24M | 0.46% |
363,371
-54,614
| -13% | -$186K |
|
78
The Mosaic Company
MOS
$10.4B
| $1.23M | 0.46% |
26,129
-15,154
| -37% | -$716K |
|
79
Douglas Emmett
DEI
$2.7B
| $1.23M | 0.45% |
54,806
+6,683
| +14% | +$150K |
|
80
Southern Copper
SCCO
$82B
| $1.14M | 0.42% |
23,982
-4,316
| -15% | -$205K |
|
|
ILPT
81
Industrial Logistics Properties Trust
ILPT
$389M
| $1.13M | 0.42% |
80,409
+13,675
| +20% | +$193K |
|
82
ScottsMiracle-Gro
SMG
$3.48B
| $1.12M | 0.42% |
14,235
+4,075
| +40% | +$322K |
|
83
AngloGold Ashanti
AU
$29.9B
| $1.08M | 0.4% |
73,082
-5,945
| -8% | -$87.9K |
|
|
DRD
84
DRDGold
DRD
$1.8B
| $1.05M | 0.39% |
178,450
-13,937
| -7% | -$81.8K |
|
85
SL Green Realty
SLG
$4.16B
| $1.03M | 0.38% |
22,201
-63
| -0.3% | -$2.91K |
|
86
Vertex Pharmaceuticals
VRTX
$102B
| $1.02M | 0.38% |
3,606
+1,828
| +103% | +$516K |
|
|
87
Moderna
MRNA
$9.36B
| $1.02M | 0.38% |
7,113
+5,771
| +430% | +$824K |
|
|
OXLC
88
Oxford Lane Capital
OXLC
$1.78B
| $1M | 0.37% |
176,034
+21,908
| +14% | +$124K |
|
89
Gold Fields
GFI
$31.3B
| $986K | 0.37% |
108,135
-42,869
| -28% | -$391K |
|
90
Nuveen Credit Strategies Income Fund
JQC
$751M
| $950K | 0.35% |
182,778
+866
| +0.5% | +$4.5K |
|
91
Regeneron Pharmaceuticals
REGN
$59.8B
| $877K | 0.33% |
1,484
+930
| +168% | +$550K |
|
|
92
Eli Lilly
LLY
$661B
| $843K | 0.31% |
+2,601
| New | +$843K |
|
|
93
Pfizer
PFE
$141B
| $803K | 0.3% |
+15,325
| New | +$803K |
|
|
94
Merck
MRK
$210B
| $796K | 0.3% |
+8,729
| New | +$796K |
|
95
Progressive
PGR
$145B
| $774K | 0.29% |
+6,659
| New | +$774K |
|
96
Synopsys
SNPS
$110B
| $774K | 0.29% |
+2,550
| New | +$774K |
|
97
Occidental Petroleum
OXY
$45.6B
| $748K | 0.28% |
+12,710
| New | +$748K |
|
98
Bristol-Myers Squibb
BMY
$96.7B
| $747K | 0.28% |
+9,704
| New | +$747K |
|
99
FS KKR Capital
FSK
$5.06B
| $747K | 0.28% |
38,465
-2,402
| -6% | -$46.6K |
|
100
Cadence Design Systems
CDNS
$94.6B
| $743K | 0.28% |
+4,953
| New | +$743K |
|